Screener
TransCode Therapeutics, Inc. RNAZ Q2 2025 earnings
Reported August 14, 2025 · Before market open
EPS-$4.94Beat by $3.74
EPS estimate-$8.68
Next report
Aug 18, 2026 (In 6 days)Versus estimates
Diluted EPS
FAQ
- When did TransCode Therapeutics, Inc. report Q2 2025 earnings?
- TransCode Therapeutics, Inc. (RNAZ) reported Q2 2025 earnings on August 14, 2025 before market open.
- What were TransCode Therapeutics, Inc.'s Q2 2025 revenue and EPS?
- TransCode Therapeutics, Inc. reported eps of $-4.94 for Q2 2025.
- Did TransCode Therapeutics, Inc. beat estimates in Q2 2025?
- EPS beat the consensus estimate of $-8.68 by $3.74.
- How did TransCode Therapeutics, Inc.'s Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 79.8% from $-24.42.
- Where can I find TransCode Therapeutics, Inc.'s Q2 2025 SEC filings?
- You can read the 10-Q periodic report (0001558370-25-011571) directly on SEC EDGAR. The filing index links above go to sec.gov.
